Comparison of the incidence, clinical features and outcomes of invasive candidiasis in children and neonates

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1471-2334

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Comparison of the incidence, clinical features and outcomes of invasive candidiasis in children and neonates ; volume:18 ; number:1 ; day:24 ; month:4 ; year:2018 ; pages:1-11 ; date:12.2018
BMC infectious diseases ; 18, Heft 1 (24.4.2018), 1-11, 12.2018

Creator: Hsu, Jen-Fu

Contributor: Lai, Mei-Yin
Lee, Chiang-Wen
Chu, Shih-Ming
Wu, I-Hsyuan
Huang, Hsuan-Rong
Lee, I-Ta
Chiang, Ming-Chou
Fu, Ren-Huei
Tsai, Ming-Horng
SpringerLink (Online service)

DOI: 10.1186/s12879-018-3100-2

URN: urn:nbn:de:101:1-2018070101514943725918

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:21 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Hsu, Jen-Fu
Lai, Mei-Yin
Lee, Chiang-Wen
Chu, Shih-Ming
Wu, I-Hsyuan
Huang, Hsuan-Rong
Lee, I-Ta
Chiang, Ming-Chou
Fu, Ren-Huei
Tsai, Ming-Horng
SpringerLink (Online service)

Other Objects (12)

An experimental porcine model of invasive candidiasis

Incidence and outcome of invasive candidiasis in intensive care units (ICUs) in Europe: results of the EUCANDICU project

Empirical Therapy for Invasive Candidiasis in Critically Ill Patients

Invasive Candidiasis in the Elderly: Considerations for Drug Therapy

Current patient perspectives of vulvovaginal candidiasis: incidence, symptoms, management and post-treatment outcomes

Efficacy and safety of non-invasive respiratory support in neonates

Highly-cited estimates of the cumulative incidence and recurrence of vulvovaginal candidiasis are inadequately documented

Survey of incidence, lifetime prevalence, and treatment of self-reported vulvovaginal candidiasis, United States, 2020

Microbiota-driven interleukin-17 production provides immune protection against invasive candidiasis

Procalcitonin for the diagnosis of invasive candidiasis: what is the evidence?

Cost-utility analysis of caspofungin and fluconazole for primary treatment of invasive candidiasis and candidemia in Ethiopia

Anidulafungin compared with fluconazole in severely ill patients with candidemia and other forms of invasive candidiasis: Support for the 2009 IDSA treatment guidelines for candidiasis

An experimental porcine model of invasive candidiasis

Incidence and outcome of invasive candidiasis in intensive care units (ICUs) in Europe: results of the EUCANDICU project

Empirical Therapy for Invasive Candidiasis in Critically Ill Patients

Invasive Candidiasis in the Elderly: Considerations for Drug Therapy

Current patient perspectives of vulvovaginal candidiasis: incidence, symptoms, management and post-treatment outcomes

Efficacy and safety of non-invasive respiratory support in neonates

Highly-cited estimates of the cumulative incidence and recurrence of vulvovaginal candidiasis are inadequately documented

Survey of incidence, lifetime prevalence, and treatment of self-reported vulvovaginal candidiasis, United States, 2020

Microbiota-driven interleukin-17 production provides immune protection against invasive candidiasis

Procalcitonin for the diagnosis of invasive candidiasis: what is the evidence?

Cost-utility analysis of caspofungin and fluconazole for primary treatment of invasive candidiasis and candidemia in Ethiopia

Anidulafungin compared with fluconazole in severely ill patients with candidemia and other forms of invasive candidiasis: Support for the 2009 IDSA treatment guidelines for candidiasis

An experimental porcine model of invasive candidiasis

Incidence and outcome of invasive candidiasis in intensive care units (ICUs) in Europe: results of the EUCANDICU project

Empirical Therapy for Invasive Candidiasis in Critically Ill Patients

Invasive Candidiasis in the Elderly: Considerations for Drug Therapy

Current patient perspectives of vulvovaginal candidiasis: incidence, symptoms, management and post-treatment outcomes

Efficacy and safety of non-invasive respiratory support in neonates

Highly-cited estimates of the cumulative incidence and recurrence of vulvovaginal candidiasis are inadequately documented

Survey of incidence, lifetime prevalence, and treatment of self-reported vulvovaginal candidiasis, United States, 2020

Microbiota-driven interleukin-17 production provides immune protection against invasive candidiasis

Procalcitonin for the diagnosis of invasive candidiasis: what is the evidence?

Cost-utility analysis of caspofungin and fluconazole for primary treatment of invasive candidiasis and candidemia in Ethiopia

Anidulafungin compared with fluconazole in severely ill patients with candidemia and other forms of invasive candidiasis: Support for the 2009 IDSA treatment guidelines for candidiasis

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Comparison of the incidence, clinical features and outcomes of invasive candidiasis in children and neonates

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

An experimental porcine model of invasive candidiasis

Incidence and outcome of invasive candidiasis in intensive care units (ICUs) in Europe: results of the EUCANDICU project

Empirical Therapy for Invasive Candidiasis in Critically Ill Patients

Invasive Candidiasis in the Elderly: Considerations for Drug Therapy

Current patient perspectives of vulvovaginal candidiasis: incidence, symptoms, management and post-treatment outcomes

Efficacy and safety of non-invasive respiratory support in neonates

Highly-cited estimates of the cumulative incidence and recurrence of vulvovaginal candidiasis are inadequately documented

Survey of incidence, lifetime prevalence, and treatment of self-reported vulvovaginal candidiasis, United States, 2020

Microbiota-driven interleukin-17 production provides immune protection against invasive candidiasis

Procalcitonin for the diagnosis of invasive candidiasis: what is the evidence?

Cost-utility analysis of caspofungin and fluconazole for primary treatment of invasive candidiasis and candidemia in Ethiopia

Anidulafungin compared with fluconazole in severely ill patients with candidemia and other forms of invasive candidiasis: Support for the 2009 IDSA treatment guidelines for candidiasis

An experimental porcine model of invasive candidiasis

Incidence and outcome of invasive candidiasis in intensive care units (ICUs) in Europe: results of the EUCANDICU project

Empirical Therapy for Invasive Candidiasis in Critically Ill Patients

Invasive Candidiasis in the Elderly: Considerations for Drug Therapy

Current patient perspectives of vulvovaginal candidiasis: incidence, symptoms, management and post-treatment outcomes

Efficacy and safety of non-invasive respiratory support in neonates

Highly-cited estimates of the cumulative incidence and recurrence of vulvovaginal candidiasis are inadequately documented

Survey of incidence, lifetime prevalence, and treatment of self-reported vulvovaginal candidiasis, United States, 2020

Microbiota-driven interleukin-17 production provides immune protection against invasive candidiasis

Procalcitonin for the diagnosis of invasive candidiasis: what is the evidence?

Cost-utility analysis of caspofungin and fluconazole for primary treatment of invasive candidiasis and candidemia in Ethiopia

Anidulafungin compared with fluconazole in severely ill patients with candidemia and other forms of invasive candidiasis: Support for the 2009 IDSA treatment guidelines for candidiasis

An experimental porcine model of invasive candidiasis

Incidence and outcome of invasive candidiasis in intensive care units (ICUs) in Europe: results of the EUCANDICU project

Empirical Therapy for Invasive Candidiasis in Critically Ill Patients

Invasive Candidiasis in the Elderly: Considerations for Drug Therapy

Current patient perspectives of vulvovaginal candidiasis: incidence, symptoms, management and post-treatment outcomes

Efficacy and safety of non-invasive respiratory support in neonates

Highly-cited estimates of the cumulative incidence and recurrence of vulvovaginal candidiasis are inadequately documented

Survey of incidence, lifetime prevalence, and treatment of self-reported vulvovaginal candidiasis, United States, 2020

Microbiota-driven interleukin-17 production provides immune protection against invasive candidiasis

Procalcitonin for the diagnosis of invasive candidiasis: what is the evidence?

Cost-utility analysis of caspofungin and fluconazole for primary treatment of invasive candidiasis and candidemia in Ethiopia

Anidulafungin compared with fluconazole in severely ill patients with candidemia and other forms of invasive candidiasis: Support for the 2009 IDSA treatment guidelines for candidiasis

Related objects

Reset password